Should you buy Simulations Plus stock? (NasdaqCM:SLP). Let's see how it does in our automated value investing analysis system.
(Simulations Plus stock price per share)
||SLP Fair Price
(based on intrinsic value)
|SLP Safety Price (based on a variable margin of safety)||$6.12|
|PE Ratio versus Sector||255% higher than other Healthcare stocks|
|PE Ratio versus Industry||7% higher than other Health Information Services stocks|
|Free Cash Flow Jitter||28%|
|Dividend Yield||1%||Shares Shorted||1,603,687|
We believe that Simulations Plus may be worth examining further. It's making money, which is a very positive sign. Is it on sale?
Simulations Plus looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.
Does Simulations Plus have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
Most Popular Articles